Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis.
To date, no attempt has been made to study alterations occurring in the amino acid profile in chronic models of thioacetamide-induced liver cirrhosis. In this work, changes in serum amino acids and proteins in rats with thioacetamide-induced liver cirrhosis are reported, together with changes in enzyme activities in the liver and serum. Seventeen female Wistar rats were used. Eight rats were given 300 mg thioacetamide/l in drinking water for 4 months and nine rats were given water ad libitum during the same time-period. Significant increases in glycine, alanine, serine, methionine, glutamate, ornithine, phenylalanine, tyrosine, histidine and proline were observed in rats with the resulting experimental liver cirrhosis. Threonine, taurine, glutamine, lysine and citrulline tended to increase while isoleucine, leucine, aspartate, arginine and tryptophan tended to decrease. Total and nonessential amino acids increased significantly in cirrhotic animals. Total essential and aromatic amino acids tended to increase in the thioacetamide-treated group, whereas branched chain amino acids tended to decrease in the same group. Regarding serum proteins, a decrease in albumin concentration in the thioacetamide-treated animals was the only change detected. The liver enzyme activities under observation (aspartate and alanine aminotransferases, glutamate dehydrogenase and threonine deaminase) were lower in the thioacetamide group. Decreases were significant for both transaminases and threonine deaminase. Results for serum activities showed that transaminases did not change in thioacetamide-treated rats in comparison with controls. In contrast, alkaline phosphatase rose dramatically in cirrhotic rats. We conclude that the serum amino acid pattern in this chronic model of liver cirrhosis resembles in part that of the corresponding human disease.
Fontana
L
L
Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Granada, Spain.
Moreira
E
E
Torres
M I
MI
Fernández
M I
MI
Ríos
A
A
Sánchez de Medina
F
F
Gil
A
A
D000284:Administration, Oral; D000596:Amino Acids / Q000097:blood*; D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D004326:Drinking; D005260:Female; D005969:Glutamate Dehydrogenase / Q000378:metabolism; D008099:Liver / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D008106:Liver Cirrhosis, Experimental / Q000097:blood* / Q000139:chemically induced / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D013853:Thioacetamide / Q000008:administration & dosage / Q000633:toxicity*; D013913:Threonine Dehydratase / Q000378:metabolism; D000637:Transaminases / Q000097:blood / Q000378:metabolism
D000596:Amino Acids; D001798:Blood Proteins; D013853:Thioacetamide; D005969:Glutamate Dehydrogenase; D000637:Transaminases; D013913:Threonine Dehydratase